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Abstract
Summary Gene-based association approach could be
regarded as a complementary analysis to the single
SNP association analysis. We meta-analyzed the findings
from the gene-based association approach using the
genome-wide association studies (GWAS) data from
Chinese and European subjects, confirmed several well
established bone mineral density (BMD) genes, and
suggested several novel BMD genes.
Introduction The introduction of GWAS has greatly
increased the number of genes that are known to be
associated with common diseases. Nonetheless, such a
single SNP GWAS has a lower power to detect genes
with multiple causal variants. We aimed to assess the
association of each gene with BMD variation at the spine
and hip using gene-based GWAS approach.
Methods We studied 778 Hong Kong Southern Chinese
(HKSC) women and 5,858 Northern Europeans (dCG); age,
sex, and weight were adjusted in the model. The main
outcome measure was BMD at the spine and hip.
Results Nine genes showed suggestive p value in HKSC,
while 4 and 17 genes showed significant and suggestive p
values respectively in dCG. Meta-analysis using weighted
Z-transformed test confirmed several known BMD genes
and suggested some novel ones at 1q21.3, 9q22, 9q33.2,
20p13, and 20q12. Top BMD genes were significantly
associated with connective tissue, skeletal, and muscular
system development and function (p<0.05). Gene network
inference revealed that a large number of these genes were
significantly connected with each other to form a functional
gene network, and several signaling pathways were
strongly connected with these gene networks.
Conclusion Our gene-based GWAS confirmed several
BMD genes and suggested several novel BMD genes.
Genetic contribution to BMD variation may operate
through multiple genes identified in this study in functional
gene networks. This finding may be useful in identifying
and prioritizing candidate genes/loci for further study.
Keywords Association study.Bone mineral density.
Genetic epidemiology.Meta-analysis.Osteoporosis
Introduction
Genome-wide association studies (GWAS) provide a pow-
erful approach to search for common genetic variants that
increase susceptibility to complex diseases or traits.
Nonetheless, they do not necessarily lead directly to the
gene or genes in a given locus associated with disease, nor
typically inform the broader context in which the disease
genes operate. They thus provide limited insight into the
mechanisms that drive disease. In addition, the amount of
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mostoften significantly less than the heritability estimate
for the disease. For example, a number of studies estimate
the genetic heritability for spine BMD to be as high as 80%,
but the 15 genetic loci identified for spine BMD to date
account for only ∼2.9% of the variation in spine BMD [1].
This raises the question of whether there are many more
common DNA variants with smaller effects that are not
being identified in the GWAS because of a lack of power,
whether there are many more rare variants with stronger
effect that explain the missing variation or whether it is
some combination of these two scenarios.
In the current GWAS design, a genetic association is
considered only at a single SNP locus level rather than a
gene level. The stringent genome-wide significance level
may also inflate the false-negative rate and limit its ability
to identify disease genes. Different approaches have
recently been adopted to ameliorate this situation, including
pathway-based and gene-based GWAS. Gene-based analy-
sis is a complementary approach to single-locus analysis.
Generally, this type of approach tests whether a set of SNPs
in a given gene locus is associated with a trait of interest.
Different approaches have been used to identify genes that
are associated with trait of interest, such as multiple logistic
regression for discrete trait and set-based test for discrete or
continuous trait. Nonetheless, the set-based test requires
heavy computation and therefore limits its application at a
genome-wide level. An efficient genome-wide gene-based
association method has recently been developed, based on
simulations from the multivariate normal distribution. This
approach has provided important biological insight into
disease etiology, and a number of disease genes are
expected to be identified. These genes may not contain
any SNPs that meet the genome-wide significance thresh-
old, but rather a nominal significant p value may be
observed in a number of SNPs in each of these genes.
In this study, we performed gene-based GWAS in a Hong
Kong Southern Chinese (HKSC) cohort and Icelandic
deCODE Study (dCG) [2] and performed meta-analysis of
6,636 adults by combining the results from HKSC and dCG
that examined spine and femoral neck BMD. Our findings
confirmed several well-known candidate genes and discov-
ered a number of novel candidate genes.
Materials and methods
Study population
The current meta-analysis incorporated 6,643 individuals
derived from two GWAS on BMD at the lumbar spine and
femoral neck, the HKSC Study (n=778), and dCG Study
(dCG, n=5,858) [2]. In the Hong Kong Osteoporosis Study,
800 unrelated women with extreme high or low BMD were
selected from a HKSC cohort with extreme BMD. These
subjects were selected from a database (>9,000 Southern
Han Chinese volunteers) at the Osteoporosis Centre of the
University of Hong Kong. Low-BMD subjects are defined as
those with a BMD Z-score≤−1.28 at either the lumbar spine
(LS) or femoral neck (FN) (the lowest 10% of the total
cohort). High-BMD subjects comprised individuals with
BMD Z-score≥+1.0 at either site. Subjects who reported
diseases or environmental factors that may affect BMD and
bone metabolism were excluded. The recruitment procedure
and exclusion criteria have been detailed elsewhere [3]. The
demographic data of studied population are provided in
Supplementary Table 1.
BMD and anthropometric measurements
BMD (grams per square centimeter) at the LS and FN was
measured by dual-energy X-ray absorptiometry (Hologic
QDR 4500 plus, Hologic Waltham, MA, USA) with
standard protocol. The in vivo precision of the machine
was 1.2% and 1.5% for LS and FN BMD, respectively.
Genotyping
The discovery sample was genotyped via the Infinium assay
(Illumina, San Diego, CA) with Human610-quad chip,
including 564,214 SNPs. PLINK (version 1.04) was used for
data managementand quality-control statistics. Sevenhundred
seventy-eight individuals and 488,853 SNPs were retained for
analysis following application of strict quality-control criteria.
Subjects were excluded according to the following criteria: (1)
genotyping call rate <95% (n=5), (2) autosomal heterozygos-
ity <27% or >31% (the same five subjects with low
genotyping call rate), (3) being related or identical to other
individuals in the sample (n=7), and (4) discordance of
observed gender and estimated sex (n=3). SNPs were
excluded if (1) genotyping call rate was ≤95% (1,158 SNPs),
(2) Hardy–Weinberg equilibrium p value <1.0×10
−4 (904
SNPs), (3) minor allele frequency <0.01 (73,589 SNPs). The
average genotyping call rate of retained SNPs was 99.91%.
In silico gene-based GWAS of European subjects
All GWA data for spine and hip BMD of dCG were
retrieved from the publication [2].
Phenotype modeling
To be comparable and compatible in meta-analysis, both
studies used standardized residuals of raw BMDs following
adjustment for age, weight, and sex (dCG) in the linear
regression model.
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We defined the gene locus by its position based on UCSC
and ±50 kb. Fifty kilobytes is the mean distance between
the top intergenic SNPs and the nearest genes identified in
the latest meta-analysis of GWAS of BMD [1]. SOX6 and
MEF2C were excluded from the mean distance calculation
as they were the outliers.
Statistical analysis
In the genome-wide association study, the association test
of SNPs with standardized residuals of BMD was imple-
mented via PLINK (version 1.04). For each SNP, the
asymptotic p value for the relationship between the number
of minor alleles and BMD was derived from a two-sided t
statistic assuming the minor allele has an additive effect. We
identified disease-associated genes with two stages. The
first stage was the gene-based test using a simulation
approach that took account of LD structure of different
populations based on HapMap phase two information.
Gene-based analysis in each population was done using
VEGAS [4]. In brief, each SNP was assigned to each of
17,787 autosomal genes according to positions on the
UCSC Genome Browser hg18 assembly. In order to capture
regulatory regions and SNPs in LD, the gene boundaries
were defined as 51 kb of 5′ and 3′ UTRs. Then, for a given
gene with n SNPs, association p values were first converted
to upper tail chi-squared statistics with 1 degree of freedom
(df). The observed gene-based test statistic was then the
sum of all (or a pre-defined subset) of the chi-squared 1 df
statistics within that gene. In the current study, we summed
the statistics of all SNPs located within a gene. Using the
Monte Carlo approach, a large number of multivariate
normal vectors were simulated, and the empirical gene-
based p value was calculated as the proportion of simulated
test statistics that exceeded the observed gene-based test
statistic. In the second stage, we attempted to meta-analyze
the findings from both populations, to increase statistical
power and to assess the consistency of evidence in two
ethnicities using weighted Z-transformed test as imple-
mented in the R. A weighted Z-transformed test was chosen
because it has been suggested that when the number of tests
are small, the weighted Z-transformed test performs better
than other combination probability methods, such as Fish-
er's test and generalized binomial test [5, 6].
Gene-based genome-wide significant level and suggestive
level
Among 17,640 genes included in the analysis, 14,605
overlapped with either 5′ and/or 3′ genes with the average
overlapping size per gene size (overlapping size with other
gene/gene size) 0.62. We therefore arbitrarily defined the
gene-based genome-wide significant level as 0.05/(3,035×
1+14,605×0.38)=5.8×10
−6, while the suggestive level was
1/(3,035×1+14,605×0.38)=1.2×10
−4.
Identification of enriched physiological role in genes
associated with BMD
The top 35 genes were imported into the Ingenuity
Pathways Analysis (IPA) Software (Ingenuity Systems,
Redwood City, CA, USA) to obtain networks for further
analyses and to determine whether their physiological role
was enriched. These top 35 genes were chosen because 35
was the limited number of genes/molecules required to
form a functional regulatory gene network in the later gene
network inference analysis. The enriched physiological
roles were ranked by the p values of the Fisher's Exact
Test that indicated the probability of the input gene (from
the gene-based GWAS) being associated with genes in the
physiological roles by chance.
Gene network inference via knowledge-based data mining
We next analyzed biological interactions among top hits
using the IPA tool. The gene annotations from the top hits
with suggestive p value were entered into the IPA analysis
tool to construct the biological networks of the clustered
genes. Networks are generated from the gene set by
maximizing the specific connectivity of the input genes,
which represents their interconnectedness with each other
relative to other molecules to which they are connected in
Ingenuity's Knowledge Database. Networks were limited to
35 molecules each to keep them to a functional size. The p
value of probability for the genes forming a network was
calculated using the right-tailed Fisher's Exact Test based on
the hypergeometric distribution.
Results
Genomic control of SNP data before gene-based GWAS
In single SNP GWAS of spine and hip BMD in southern
Chinese, an inflation factor of 1 was observed for both
sites. An inflation factor of 1.22 and 1.18 for spine and hip
BMD was observed in the p value distribution from the
dCG GWAS data. After correction of GC, the inflation
factor became one in both sites studied.
Identification of BMD genes in each individual study
In southern Chinese, none of the genes reached a genome-
wide significant p value (5.8×10
−6), whereas seven and two
Osteoporos Int (2012) 23:131–142 133genes reached a suggestive p value for hip and spine BMD,
respectively. The most significant gene for spine BMD was
CCDC55 with an empirical p value of 8.3×10
−5 (Table 1).
The most significant gene for femoral neck BMD was
KPNA4 with an empirical p value of 4.9×10
−5 (Table 1).
The best SNP (rs4470197) in the suggestive genes EFCAB5
and CCDC55 for spine BMD was the same. Likewise, the
best SNP (rs4680580) in the suggestive genes SMC4 and
TRIM59 for hip BMD was the same.
In European subjects, three genes (C6orf97, ESPL1, and
SP7) were significantly associated with spine BMD
(Table 2), and p values of eight genes reached suggestive
significance level. Among the three significant genes,
rs10876432 was the best SNP in two of them. For
femoral neck BMD, two genes (C6orf97 and LRP4)
reached a genome-wide significant level (Table 3), and
nine genes reached a genome-wide suggestive level. Of
the genes significantly associated with femoral neck BMD
variation, only C6orf97 was associated with BMD at both
sites in Europeans.
Meta-analysis of gene-based GWAS in southern Chinese
and Europeans
In the gene-based GWAS of spine BMD in Europeans,
C6orf97 had an empirical p value of 0. This was because
the maximum number of permutations performed was
1,000,000. If there were no simulated test statistics greater
than the observed test statistics, the empirical p value would
be 0. We replaced the “0” with 1×10
−6 for the purpose of
meta-analysis and applied weighted Z-transformed test to
combine the p values of each gene with weighting of
sample size of each study. Manhattan plots of the −log p
value of the gene-based GWAS for spine and hip BMD are
shown in Supplementary Figures 1a and 1b. The QQ plots
of the results are provided in Supplementary Figure 2. The
meta-analysis identified five genes from three genomic loci
that exceeded the gene-based GWAS significance threshold
of association with the BMD traits (Tables 4 and 5). Of
these, three loci were associated with LS BMD (Table 4)
and two with FN BMD (Table 5).
Known genes associated with BMD in previous GWAS
meta-analysis
We have previously identified two genes for spine BMD
and two genes for femoral neck BMD through a GWAS
meta-analysis approach: SP7 (meta p=4.4×10
−6)a n d
C6orf97 (meta p=7.7×10
−7)f o rs p i n eB M D ,CKAP5
(meta p=5.2×10
−6)a n dLRP4 (meta p=1.2×10
−6)f o r
femoral neck BMD. Although ESPL1 was not identified in
the previous study, it is located at the same locus as SP7 at
12q13–12q13.1.
Novel loci associated with BMD at gene-based GWA
suggestive threshold
Four and five genetic loci reached a genome-wide
suggestive level for spine and hip BMD respectively:
6q25.1 (ESR1), 9q33.2 (CDK5RAP2), 12q13 (C12orf10,
AAAS, SP1, PFDN5, MFSD5,a n dRARG), and 20q12
(EIF6) for spine BMD; 1q21.3 (LCE2A, KPRP, LCE4A,
LCE2B,a n dLCE2C), 6q25.1 (C6orf97), 9q22 (FOXE1),
11p11 (F2, C11orf49, ZNF408, and ARHGAP1), and
20p13 (ADRA1D) for hip BMD. Of these, 1q21.3, 9q22,
9q33.2, 20p13, and 20q12 were not identified as
significant BMD loci in the previous meta-analysis [1].
Enriched physiological role of the top genes
The results of a physiological role analysis (Tables 6
and 7) suggest that genes for spine BMD are involved
mainly in connective tissue development (lowest p=
3.7×10
−6) and function and skeletal and muscular
system development and function (lowest p=3.7×
10
−6). Genes for hip BMD are involved mainly in
cardiovascular system development and function (low-
est p=4.9×10
−4) and tissue morphology (lowest p=4.9×
10
−4). Connective tissue development and function
(lowest p=1.28×10
−3), digestive system development
and function (lowest p=1.28×10
−3), and embryonic
development (lowest p=1.28×10
−3) are also associated
with the hip BMD genes.
Novel gene network inference
Gene network inference was performed to evaluate
whether the gene set may represent a novel functional
gene network that may be involved in bone metabo-
lism. We generated functional gene networks from the
BMD genes using IPA. For spine BMD genes, the
most significant gene network connected 18 spine
BMD genes with 17 connecting genes with a p value
of 1×10
−46 (Fig. 1a). There were several hub genes/
molecules in this network, such as SP1, ESR1, P38
MAPK, and EPK1/2. This network was significantly
associated with connective tissue development and
function, skeletal and muscular system development
and function, and cell cycle (Fig. 1a). For femoral neck
BMD, the most significant gene network connected ten
spine BMD genes with 25 connecting genes with a p
value of 1×10
−23 (Fig. 1b). There were several hub
genes/molecules in this network, such as TNF, prosta-
glandin E2, NFkB, and F2. This network was signif-
icantly associated with cellular development, cellular
growth and proliferation, and connective tissue devel-
opment and function.
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GWA is a powerful tool that can identify genes
associated with common diseases or traits such as
BMD variation. Nonetheless, GWA studies usually focus
on the most significant individual variants without
considering the global evidence of the gene tested. It
should be noted that allelic heterogeneity (i.e., presence
of more than one susceptibility allele in a locus or gene)
greatly reduces the power for testing of an individual
SNP [7, 8]. Therefore, a gene-based test can ameliorate
the situation by simply testing the global null hypoth-
esis about the SNPs located per gene. The gene-based
test is a direct and powerful means of protecting the
overall false-positive rate when a collection of loci are
tested, because the p value from the gene-based test has
already corrected the number of SNPs included via a
simulation approach. Using gene-based analysis of GWA
data, our study confirmed several well established
candidate genes and suggested several novel genes and
loci for BMD variation. Importantly, most of these
genes did not contain any SNP that reached genome-
wide significance, so the potential importance of these
genes would not have been recognized in the absence of
gene-based association study.
An ethnic-specific BMD gene may underlie BMD
variation in southern Chinese and Europeans. In line
with the observations of our recent GWAS, there was no
overlap of genes in the significant or suggestive gene
list from HKSC and dCG populations We recently
identified a SNP rs2273601 in JAG1 that was associated
with spine BMD (p value=1.06×10
−8) in 1,520 HKSC
subjects with extreme BMD; nonetheless, only a modest
association of this SNP with spine BMD was observed in
three Caucasian cohorts (p range, 0.007–0.045) [3]. In the
current study, we observed that top hip BMD genes
were more consistent in HKSC and dCG, as reflected
by the inflation factor and the results from independent
t testing (Supplementary methods, Supplementary Figures 3
to 4, and Supplementary Table 2). The discrepancies of
gene-based association results for spine BMD in two
populations may be due to a number of factors such as
lifestyle, diet, and genetic background. Although these
factors may also affect hip BMD, the possibility that
s p i n eB M Dm a yb em o r es u s c e p t i b l et h a nh i pB M Dt o
gene and environment interaction cannot be excluded. If
this hypothesis is true, identification of gene and
environmental interaction will benefit genetic research
into osteoporosis and clinical practice.
The study design of HKSC and dCG also differed. In
our HKSC cohort, we studied subjects at the extremes
of BMD distribution. Studying subjects at the extremes
of a quantitative phenotype has proven useful in
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136 Osteoporos Int (2012) 23:131–142identifying functional rare variants [9, 10]. The genes
identified in our HKSC cohort may therefore harbor
more rare variants than the dCG cohort. Future deep
sequencing of the top hits will be required to validate
the first hypothesis. The dCG cohort also included both
men and women, while our HKSC cohort included only
women. Since sex-specific genetic architecture has been
well demonstrated for BMD variation [11–13], this
difference likely accounts for some differences in the
findings. Although the number of subjects in the HKSC
cohort was fewer, the HKSC cohort captured informa-
tion from the extreme 25% (cases, lowest 10%; super
control, highest 15%) of 3,200 subjects. Other hetero-
geneity in different ethnicities, such as lifestyle, diet,
Table 5 Top genome-wide significant genes associated with femoral neck BMD in 6,636 adults
Chr Gene Start
position
End
position
Southern Chinese (n=778) European (n=5,858) Meta p
Number
of SNPs
Test
statistic
Gene-based p Number
of SNPs
Test
statistic
Gene-based p
Significant gene
11 LRP4 46834993 46896652 10 43.6 0.016 12.000 126.5 4.0E−06 1.2E−06
11 CKAP5 46721659 46824419 13 36.9 0.065 12.000 144.9 1.1E−05 5.2E−06
Suggestive gene
6 C6orf97 151856919 151984021 69 23.9 0.978 41.000 270.1 2.0E−06 8.4E−06
11 F2 46697318 46717632 9 24.8 0.068 7.000 80.7 3.4E−05 1.7E−05
9 FOXE1 99655357 99658818 9 38.0 0.015 9.000 84.7 6.5E−05 2.2E−05
1 LCE2A 150937463 150938542 11 44.4 0.010 6.000 70.9 1.0E−04 3.2E−05
1 KPRP 150997129 151001153 16 18.4 0.329 7.000 85.3 3.6E−05 3.3E−05
1 LCE4A 150948146 150948534 12 37.1 0.023 6.000 79.5 8.9E−05 3.5E−05
20 ADRA1D 4149277 4177659 34 29.8 0.537 23.000 108.7 2.9E−05 3.6E−05
1 LCE2B 150925222 150926500 13 57.9 0.008 8.000 71.0 1.2E−04 3.7E−05
1 LCE2C 150914394 150915673 14 63.8 0.008 8.000 71.0 1.6E−04 5.0E−05
11 C11orf49 46914826 47142507 23 121.2 0.005 20.000 140.1 1.8E−04 5.2E−05
11 ZNF408 46678943 46684037 10 41.8 0.013 9.000 69.9 2.2E−04 7.9E−05
11 ARHGAP1 46655207 46678696 9 37.7 0.012 8.000 57.0 3.1E−04 1.1E−04
Table 4 Top genome-wide significant genes associated with spine BMD in 6,636 adults
Chr Gene Start
position
End
position
Southern Chinese (n=778) European (n=5,858) Meta p
Number
of SNPs
Test
statistic
Gene-based p Gene-based p Number
of SNPs
Test statistic
Significant gene
6 C6orf97 151856919 151984021 69 46.8 0.734 41 248.9 1.0E−06 1.9E−06
12 ESPL1 51948349 51973694 13 17.2 0.239 13 140.0 3.0E−06 2.3E−06
12 SP7 52006626 52015804 6 6.6 0.309 6 91.6 5.0E−06 4.4E−06
Suggestive gene
12 C12orf10 51979736 51987232 8 10.4 0.252 8 116.3 8.0E−06 6.4E−06
12 AAAS 51987506 52001679 7 9.5 0.222 8 116.3 9.0E−06 6.7E−06
12 SP1 52060245 52096493 7 5.2 0.414 7 64.8 8.0E−06 8.4E−06
12 PFDN5 51975501 51979501 8 10.4 0.227 8 116.3 1.5E−05 1.1E−05
9 CDK5RAP2 122190967 122382258 35 19.3 0.804 16 99.0 9.0E−06 1.8E−05
6 ESR1 152053323 152466101 132 113.9 0.609 61 234.0 2.7E−05 3.7E−05
12 MFSD5 51932146 51934455 11 14.1 0.271 11 73.1 8.8E−05 7.3E−05
12 RARG 51890619 51912303 12 16.6 0.211 12 71.7 1.2E−04 8.6E−05
20 EIF6 33330138 33336008 14 19.0 0.245 11 66.6 1.6E−04 1.3E−04
Osteoporos Int (2012) 23:131–142 137LD structure, might also contribute to the difference in
the strength of findings [13].
Interpretation of the gene-based results required extra
attention. For example, two spine suggestive genes
(CCDC55 and EFCAB5) identified in HKSC harbored
the SNP rs4470197 which showed a strong association
signal with spine BMD (p=8.1×10
−6). This SNP was
located between these two genes, and the gene-based p
value was partly contributed by the p value of rs4470197.
Nonetheless, it is unknown whether rs4470197 is associ-
ated with CCDC55 or EFCAB5 or both. CCDC55
(coiled-coil domain containing 55) and EFCAB5 (EF-
hand calcium binding domain 5) are newly annotated
genes with no known function; both are conserved in a
number of animals such as the chimpanzee, cow, mouse,
rat, and chicken. A future functional study is required to
validate their role in bone metabolism. The most
significant hip BMD gene identified in HKSC was
KPNA4 (karyopherin alpha 4 (importin alpha 3)). The
primary function of karyopherins is to recognize nuclear
localization signals (NLSs) and dock NLS-containing
proteins to the nuclear pore complex. A number of bone
genes contain NLS, such as RUNX2 and PTHrP. A recent
study [14] demonstrated that NLS of PTHrP regulates
skeletal development, including bone mass and osteoblast
development. Therefore, defective recognition of NLS
may affect bone metabolism.
The findings in the dCG cohort were similar to the
findings in meta-analysis, despite the fact that CKAP
became significant and C6orf97 became insignificant in
the meta-analysis for hip BMD. In the meta-analysis, we
identified a number of gene loci that have been implicated
in bone metabolism in the latest meta-analysis of GWAS in
19,195 subjects [1], such as 6q25 and 12q13 for spine
B M Da n d1 1 p 1 1 . 2f o rh i pB M D .W ea l s oi d e n t i f i e da
number of novel suggestive loci associated with BMD.
1q21.3 encompasses late cornified envelope protein
(LCE) gene cluster and keratinocyte proline-rich protein
(KPRP) and is known as the epidermal differentiation
complex [15]. Both LCE2A and LCE4A were induced and
responsive to the extracellular calcium level and UV
irradiation. Though thought to be mainly involved in skin
conditions (such as psoriasis [16]), deletion of LCEs was
also associated with rheumatoid arthritis [17], thus
offering an insight into the role of LCEs in the
autoimmune system. The mammalian Forkhead Box
(Fox) family of transcription factor is involved in a
number of biological processes such as tissue-specific
transcription, cell fate determination during embryogen-
esis, and cell survival. FOXE1 at 9q22 was identified as a
BMD candidate gene in the current study. FOXE1 is
involved in thyroid organogenesis and development of
cleft palate [18, 19]. A recent study has shown that this
gene is also associated with skeletogenesis in zebrafish.
Knocking down of FOXE1 in zebrafish using morpho-
lino resulted in severe reduction in the expression of
sox9a, col1a1,a n drunx2. In addition, this gene and
another candidate gene in the same gene family identified
in the recent meta-analysis [1], FOXL1, are downstream
targets of Hedgehog-Gli signaling pathway [20, 21]. The
Hedgehog and Gli signaling pathway is important in bone
development [22] and osteoblast differentiation [23].
CDK5RAP2 (CDK5 regulatory subunit associated protein
2) at 9q33.2 is involved in the regulation of neuronal
differentiation and associated with microcephaly [24].
Microcephaly is a disease in which head size is smaller
than average and is often associated with osteoporosis
[25, 26]. Adrenergic, alpha-1D-receptor (ADRA1D)a t
20p13 is a G-protein coupled receptor that mediates
actions in the sympathetic nervous system through a
Table 6 Bio-function
enrichment analysis of spine
BMD genes
Physiological role p value range Number of molecules
Connective tissue development and function 3.67E−06 to 0.049 4
Skeletal and muscular system development and function 3.67E−06 to 0.046 6
Tissue morphology 6.31E−06 to 0.046 4
Digestive system development and function 1.95E−03 to 0.017 4
Embryonic development 1.95E−03 to 0.029 4
Table 7 Bio-function enrich-
ment analysis of hip BMD genes Physiological role p value range Number of molecules
Cardiovascular system development and function 4.93E−04 to 0.050 4
Tissue morphology 4.93E−04 to 0.043 6
Connective tissue development and function 1.28E−03 to 0.034 3
Digestive system development and function 1.28E−03 to 0.017 3
Embryonic development 1.28E−03 to 0.036 2
138 Osteoporos Int (2012) 23:131–142number of neurotransmitters, such as catecholamines,
epinephrine, and norepinephrine. The sympathetic ner-
vous system is important in bone mass regulation [27,
28]; male mice without beta1/beta2 adrenergic receptor
have increased cortical bone mass [29]. The role of
ADRA1D in bone metabolism has been demonstrated in
MC3T3-E1 osteoblast-like cells, in which ADRA1D is
expressed in MC3T3E-1 cells, and RANKL expression is
Fig. 1 a Inference of gene
regulatory networks using spine
BMD genes. b Inference of gene
regulatory networks using hip
BMD genes
Osteoporos Int (2012) 23:131–142 139regulated via alpha-adrenergic receptor stimulation in
osteoblasts [30]. Eukaryotic translation initiation factor
6 (eIF6) at 20q12 is a gene that controls translation at the
rate-limiting step of initiation. Recently, Gandin et al.
demonstrated that heterozygous mice of eIF6 had fewer
hepatic and adipose cells due to impaired G1/S cell cycle
progression [31]. They found that the reduction of
adipose tissue was due to a decreased proliferation of
pre-adipocytes derived from mesenchymal stem cells.
Although bone phenotype was not investigated in their
study, we believe that eIF6 could affect bone metabolism
by regulating the cell number of osteoblasts, since both
adipocytes and osteoblasts are derived from the same
progenitor–mesenchymal stem cell; eIF6 also regulates
Wnt/beta-catenin signaling via regulation of beta-catenin
synthesis [32].
Collectively, our data showed that the BMD genes
identified in our meta-analysis play an important role in
bone metabolism. Although additional studies will be
necessary to validate their function, our current findings
indicate that these BMD genes are involved in
connective tissue development and function and skeletal
and muscular system development and function using
bio-function analysis implemented in IPA (p<0.05)
(Tables 6 and 7). Due to the limitation of genechip,
gene-based GWAS may not be able to identify BMD
genes if the SNP coverage of the BMD genes is low. One
method to remedy this is to perform more genotyping
with denser SNP; another method is to perform gene
network inference to identify genes that are connected
with other BMD genes. Using the gene network inference
approach, several bone-related hub genes or complexes
have been identified, such as ERK1/2 [33, 34], P38
MAPK [35, 36]( F i g .1a), prostaglandin E2 [37], and TNF
[38]( F i g .1b). Overlaying the gene network with known
canonical signaling pathways revealed that aryl hydro-
carbon receptor signaling; role of osteoblasts, osteo-
clasts, and chondrocytes in rheumatoid arthritis; and
role of macrophages, fibroblasts, and endothelial cells
in rheumatoid arthritis (7 genes out of 35 genes in each
signaling pathway) were the predominant themes of the
spine BMD gene network (Supplementary Table 3a),
whereas acute phase response signaling (8 genes out of 35
genes) was the predominant theme of the hip BMD gene
network (Supplementary Table 3b). Interestingly, acute
phase response was one of the underlying mechanisms of
action of bisphosphonate in the treatment of osteoporosis
[39]. Our findings suggest that hip BMD genes F2,
MBL2,a n dHMOX1 may be the genes involved in
bisphosphonate treatment and may be used to monitor
treatment response.
There are a number of limitations in the current
gene-based GWAS. First, our definition of gene-based
GWAS significance level may not be accurate. The most
accurate way would be to use simulation; however, this
would require extremely heavy computations, as the
number of SNPs included in each study and the number
of independent genes will vary from study to study. The
LD structure also varies in different ethnicities. None-
theless,ourgene-basedGWASsignificantlevel5.8×10
−6 was
not much different to the conservative Bonferroni-corrected
GWAS significance level of 2.8×10
−6 (=0.05/17,640, as-
suming each gene is independent to each other).
Second, our definition of the gene locus (±50 kb 5′
upstream and 3′ downstream of the coding region)
might strongly affect the test statistics and hence the
gene-based p value. Noting that large boundaries lead to a
longer overlapping region with the neighbor genes, hence
some markers are included in multiple genes. Thus, we
justified how long the boundaries should be included by
averaging the distance between the top intergenic SNPs
identified in the recent meta-analysis of GWAS to the
nearest coding genes [1]. Notably, the highly significant
SNP may also inflate the test statistics in a number of
nearby genes, which poses interpretation difficulty.
Thirdly, although a gene-based approach can identify
genes with multiple causal SNPs with small effect size,
it cannot identify genes with only one very significant
SNP, while other SNPs in the gene do not show any
significant p value. Fourthly, we did not account for the
heterogeneity in the meta-analysis although there is
obvious heterogeneity between HKSC and dCG studies
(as reflected by the Q statistics, data not shown).
Moreover, since the sample size of the dCG cohort was
much larger than the HKSC cohort, many significant p
values of the top findings were driven primarily by the
dCG study. Caution should therefore be exercised in
interpreting meta-analysis findings, especially when our
current data suggested that there was a large genetic
heterogeneity for spine BMD present between Chinese
and European. Lastly, correction for stratification or any
inflation has not been established in gene-based GWAS
study; therefore, all QC should be done in the single-locus
GWAS before performing the gene-based GWAS.
In conclusion, our results demonstrate the potential
applicability of a gene-based approach to the interpretation
and further mining of GWAS data. The importance of a
gene-based approach is that single-locus GWAS mainly
focuses on the association between a single marker and
disease trait. It may not be able to identify a disease
gene that harbors several causal variants with small
effect size (allelic heterogeneity). Testing the overall
effect of all SNPs in a gene, thus leveraging this
information, may provide significant power to identify
disease genes. In this study, we identified and/or confirmed a
number of BMD genes. These BMD genes were
140 Osteoporos Int (2012) 23:131–142significantly enriched in connective tissue development
and function and skeletal and muscular system devel-
opment and function. Using a gene network inference
approach, we observed that a large number of BMD
genes were connected with each other and contributed
to a significant physiological function related to bone
metabolism. Our approach suggests a concept of how
variation in multiple genes linked in a functional gene
network contributes to BMD variation and provides a
useful tool to reveal the hidden information of GWAS
that would be missed in single SNP analysis.
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